臨床試驗

Strategy TO Prevent Decompensated Heart Failure

NCT：NCT06641921 · COMPLETED

NCT IDNCT06641921

狀態COMPLETED

開始日期2024-05-01

完成時間2026-05-01

SponsorSeerlinq s. r. o. (OTHER)

First posted2024-10-15

Last updated2026-10-07

簡要摘要

The goal of this prospective, multicenter, single-arm, open-label clinical trial (Strategy TO Prevent Decompensated Heart Failure) is to evaluate the 12-month incidence of heart failure hospitalization (HFH) and all cause mortality in patients managed with haemodynamically guided treatment using the Seerlinq telemedical monitoring system.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。